Back
Meritage Homes Vs. Cytokinetics Industry Stock Comparison
Sell
50
MTH
Meritage Homes
Last Price:
162.75
Seasonality Move:
2.11%
Buy
55
CYTK
Cytokinetics
Last Price:
53.96
Seasonality Move:
7.55%
Sell
50
Meritage Homes (MTH)
is a Sell
Is Meritage Homes a Buy, Sell or Hold?
- The current Meritage Homes [MTH] share price is $162.74. The Score for MTH is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- MTH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Cytokinetics (CYTK)
is a Buy
Is Cytokinetics a Buy, Sell or Hold?
- The current Cytokinetics [CYTK] share price is $53.93. The Score for CYTK is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MTH Stock Price Chart
What is Meritage Homes's stock price today?
-
The Meritage Homes share price today is $162.74
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MTH is experiencing slight selling pressure.
CYTK Stock Price Chart
What is Cytokinetics's stock price today?
-
The Cytokinetics share price today is $53.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing buying pressure, which is a positive indicator for future bullish movement.
MTH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.67 | Sell |
| Relative Strength Index (14 RSI): | 39.16 | Sell |
| Chaikin Money Flow: | -123260 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (168.98 - 181.2) | Sell |
| Bollinger Bands (100): | (154.71 - 174.11) | Sell |
CYTK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.04 | Sell |
| Relative Strength Index (14 RSI): | 46.58 | Sell |
| Chaikin Money Flow: | 781761 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.51 - 58.99) | Sell |
| Bollinger Bands (100): | (57.71 - 76.51) | Sell |
MTH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 169.32 | Sell |
| 20-day SMA: | 173.2 | Sell |
| 50-day SMA: | 169.38 | Sell |
| 200-day SMA: | 152.71 | Buy |
| 8-day EMA: | 168.44 | Sell |
| 20-day EMA: | 171.4 | Sell |
| 50-day EMA: | 170.12 | Sell |
| 200-day EMA: | 155.38 | Buy |
CYTK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.47 | Buy |
| 20-day SMA: | 52.83 | Buy |
| 50-day SMA: | 60.85 | Sell |
| 200-day SMA: | 55.3 | Sell |
| 8-day EMA: | 53.07 | Buy |
| 20-day EMA: | 54.08 | Sell |
| 50-day EMA: | 58.8 | Sell |
| 200-day EMA: | 57.11 | Sell |
Meritage Homes Earnings Growth & MTH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.47 per share, an increase this year of $0.49 per share, and an increase next year of $1.06 per share.
Cytokinetics Earnings Growth & CYTK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.01 per share, an increase this year of $0.60 per share, and an increase next year of $0.05 per share.
Meritage Homes Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cytokinetics Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||